{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:06Z","timestamp":1790276346298,"version":"4.1.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Science and technology development plan project of Jilin Province, China","award":["YDZJ202201ZYTS588"],"award-info":[{"award-number":["YDZJ202201ZYTS588"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06221-z","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:13:45Z","timestamp":1790230425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting Alzheimer\u2019s Disease Through the Somatostatin\u2013Mitochondria Axis"],"prefix":"10.1007","volume":"63","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-bo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-qi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jun","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0209-798X","authenticated-orcid":false,"given":"Run-hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"6221_CR1","doi-asserted-by":"publisher","unstructured":"Chinnathambi S (2025) Tau and Amyloid beta causes microglial activation in Alzheimer\u2019s disease. Adv Clin Chem 128:83\u2013107. https:\/\/doi.org\/10.1016\/bs.acc.2025.06.002","DOI":"10.1016\/bs.acc.2025.06.002"},{"key":"6221_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.54101\/acen.2023.2.10","volume":"17","author":"MA Mukhamedyarov","year":"2023","unstructured":"Mukhamedyarov MA, Akhmadieva LA, Nagiev KK, Zefirov AL (2023) State-of-the-Art Technologies for Studying Cellular and Molecular Mechanisms Underlying Alzheimer\u2019s Disease. Annals of Clinical and Experimental Neurology 17:75\u201383. https:\/\/doi.org\/10.54101\/acen.2023.2.10","journal-title":"Annals of Clinical and Experimental Neurology"},{"key":"6221_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X (2021) Role of lysosomes in physiological activities, diseases, and therapy. J Hematol Oncol 14:79. https:\/\/doi.org\/10.1186\/s13045-021-01087-1","journal-title":"J Hematol Oncol"},{"key":"6221_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song T, Song X, Zhu C, Patrick R, Skurla M, Santangelo I et al (2021) Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev 72:101503. https:\/\/doi.org\/10.1016\/j.arr.2021.101503","journal-title":"Ageing Res Rev"},{"key":"6221_CR5","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","volume":"15","author":"R Tenchov","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA (2024) Alzheimer\u2019s Disease: Exploring the Landscape of Cognitive Decline. ACS Chem Neurosci 15:3800\u20133827. https:\/\/doi.org\/10.1021\/acschemneuro.4c00339","journal-title":"ACS Chem Neurosci"},{"key":"6221_CR6","doi-asserted-by":"publisher","unstructured":"Pinky U, Wali Z, Neha u, Tiwari P, El-Tanani M, Rabbani SA\u00a0et al (2026) Aging and Alzheimer\u2019s: the critical role of mitochondrial dysfunction and synaptic alterations. Front Synaptic Neurosci 17.https:\/\/doi.org\/10.3389\/fnsyn.2025.1676317","DOI":"10.3389\/fnsyn.2025.1676317"},{"key":"6221_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00525","author":"KC McGill Percy","year":"2025","unstructured":"McGill Percy KC, Liu Z, Qi X (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease: guiding the path to targeted therapies. Neurotherapeutics. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00525","journal-title":"Neurotherapeutics"},{"key":"6221_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111720","volume":"25","author":"S Kazemeini","year":"2024","unstructured":"Kazemeini S, Nadeem-Tariq A, Shih R, Rafanan J, Ghani N, Vida TA (2024) From plaques to pathways in Alzheimer\u2019s disease: the mitochondrial-neurovascular-metabolic hypothesis. Int J Mol Sci 25:11720. https:\/\/doi.org\/10.3390\/ijms252111720","journal-title":"Int J Mol Sci"},{"key":"6221_CR9","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","volume":"33","author":"R Wasim","year":"2025","unstructured":"Wasim R (2025) Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer\u2019s disease. Inflammopharmacology 33:5273\u20135289. https:\/\/doi.org\/10.1007\/s10787-025-01916-6","journal-title":"Inflammopharmacology"},{"key":"6221_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02699-w","author":"X Li","year":"2025","unstructured":"Li X, Wu Z, Si X, Li J, Wu G, Wang M (2025) The role of mitochondrial dysfunction in the pathogenesis of Alzheimer\u2019s disease and future strategies for targeted therapy. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-025-02699-w","journal-title":"Eur J Med Res"},{"key":"6221_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36470","author":"J Ren","year":"2024","unstructured":"Ren J, Xiang B, Xueling L, Han X, Yang Z, Zhang M et al (2024) Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer\u2019s disease. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36470","journal-title":"Heliyon"},{"key":"6221_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117253","volume":"421","author":"V Bhatia","year":"2021","unstructured":"Bhatia V, Sharma S (2021) Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J Neurol Sci 421:117253. https:\/\/doi.org\/10.1016\/j.jns.2020.117253","journal-title":"J Neurol Sci"},{"key":"6221_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167617","volume":"1871","author":"C Pal","year":"2025","unstructured":"Pal C (2025) Mitochondria-targeting by small molecules against Alzheimer\u2019s disease: a mechanistic perspective. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1871:167617. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167617","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"6221_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1484373","author":"S Wang","year":"2025","unstructured":"Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease: a key frontier for future targeted therapies. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1484373","journal-title":"Front Immunol"},{"key":"6221_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00513","author":"M Massaro","year":"2025","unstructured":"Massaro M, Baudo G, Lee H, Liu H, Blanco E (2025) Nuclear respiratory factor-1 (NRF1) induction drives mitochondrial biogenesis and attenuates amyloid beta-induced mitochondrial dysfunction and neurotoxicity. Neurotherapeutics. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00513","journal-title":"Neurotherapeutics"},{"key":"6221_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells13010012","volume":"13","author":"MCF de Veij","year":"2023","unstructured":"de Veij MCF, Smit AB, Henning RH, van Kesteren RE (2023) Mitochondrial Targeting against Alzheimer\u2019s Disease: Lessons from Hibernation. Cells 13:12. https:\/\/doi.org\/10.3390\/cells13010012","journal-title":"Cells"},{"key":"6221_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111491","volume":"142","author":"J Hroudov\u00e1","year":"2025","unstructured":"Hroudov\u00e1 J, Fi\u0161ar Z (2025) Targeting mitochondrial dysfunction in Alzheimer\u2019s disease: New findings and perspectives. Prog Neuropsychopharmacol Biol Psychiatry 142:111491. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111491","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6221_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.34172\/biomedrb.2024.04","volume":"2","author":"A Namvaran Abbas-Abad","year":"2024","unstructured":"Namvaran Abbas-Abad A, Seyfizadeh N, Farzipour M, Pasokh A, Salatin S, Yazdanfar N (2024) Amyloid Beta and Mitochondrial Perturbations: An Update on Mechanisms and Methods. Biomedical Research Bulletin 2:18\u201328. https:\/\/doi.org\/10.34172\/biomedrb.2024.04","journal-title":"Biomedical Research Bulletin"},{"key":"6221_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07062-1","author":"X Xiong","year":"2024","unstructured":"Xiong X, Hou J, Zheng Y, Jiang T, Zhao X, Cai J et al (2024) NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer\u2019s disease via ATF4-dependent mitochondrial UPR. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-024-07062-1","journal-title":"Cell Death Dis"},{"key":"6221_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102957","volume":"114","author":"OF Sultana","year":"2026","unstructured":"Sultana OF, Bandaru M, Bushra MSTA, Reddy PH, Reddy AP (2026) Serotonin-mediated regulation of mitophagy in Alzheimer\u2019s disease: Mechanistic insights and therapeutic potential. Ageing Res Rev 114:102957. https:\/\/doi.org\/10.1016\/j.arr.2025.102957","journal-title":"Ageing Res Rev"},{"key":"6221_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103547","volume":"28","author":"K Kalani","year":"2023","unstructured":"Kalani K, Chaturvedi P, Chaturvedi P, Kumar Verma V, Lal N, Awasthi SK et al (2023) Mitochondrial mechanisms in Alzheimer\u2019s disease: Quest for therapeutics. Drug Discovery Today 28:103547. https:\/\/doi.org\/10.1016\/j.drudis.2023.103547","journal-title":"Drug Discovery Today"},{"key":"6221_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mito.2023.09.003","volume":"73","author":"H Verma","year":"2023","unstructured":"Verma H, Gangwar P, Yadav A, Yadav B, Rao R, Kaur S et al (2023) Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer\u2019s disease. Mitochondrion 73:19\u201329. https:\/\/doi.org\/10.1016\/j.mito.2023.09.003","journal-title":"Mitochondrion"},{"key":"6221_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091252","author":"D Steffan","year":"2025","unstructured":"Steffan D, Pezzini C, Esposito M, Franco-Romero A (2025) Mitochondrial aging in the CNS: unravelling implications for neurological health and disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom15091252","journal-title":"Biomolecules"},{"key":"6221_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tins.2022.12.001","volume":"46","author":"JJ Collier","year":"2023","unstructured":"Collier JJ, Ol\u00e1hov\u00e1 M, McWilliams TG, Taylor RW (2023) Mitochondrial signalling and homeostasis: from cell biology to neurological disease. Trends Neurosci 46:137\u2013152. https:\/\/doi.org\/10.1016\/j.tins.2022.12.001","journal-title":"Trends Neurosci"},{"key":"6221_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M, S\u00e1 J, da Cruz ESO (2022) Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett 596:1095\u20131110. https:\/\/doi.org\/10.1002\/1873-3468.14298","journal-title":"FEBS Lett"},{"key":"6221_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114596","volume":"162","author":"J Panes-Fernandez","year":"2023","unstructured":"Panes-Fernandez J, Godoy PA, Gavilan J, Ram\u00edrez-Molina O, Burgos CF, Marileo A et al (2023) TG2 promotes amyloid beta aggregates: impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer\u2019s disease. Biomed Pharmacother 162:114596. https:\/\/doi.org\/10.1016\/j.biopha.2023.114596","journal-title":"Biomed Pharmacother"},{"key":"6221_CR27","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1007\/s12035-024-04468-y","volume":"62","author":"MHED Moawad","year":"2024","unstructured":"Moawad MHED, Serag I, Alkhawaldeh IM, Abbas A, Sharaf A, Alsalah S et al (2024) Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer\u2019s disease: an educational literature review. Mol Neurobiol 62:6785\u20136810. https:\/\/doi.org\/10.1007\/s12035-024-04468-y","journal-title":"Mol Neurobiol"},{"key":"6221_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03363-0","volume":"22","author":"G Zhang","year":"2025","unstructured":"Zhang G, Wei H, Zhao A, Yan X, Zhang X, Gan J et al (2025) Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders. J Neuroinflammation 22:34. https:\/\/doi.org\/10.1186\/s12974-025-03363-0","journal-title":"J Neuroinflammation"},{"key":"6221_CR29","doi-asserted-by":"publisher","unstructured":"Almeida VN (2023) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Qeios.https:\/\/doi.org\/10.32388\/goy6dk","DOI":"10.32388\/goy6dk"},{"key":"6221_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102270","volume":"96","author":"VN Almeida","year":"2024","unstructured":"Almeida VN (2024) Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Ageing Res Rev 96:102270. https:\/\/doi.org\/10.1016\/j.arr.2024.102270","journal-title":"Ageing Res Rev"},{"key":"6221_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s12276-021-00580-4","volume":"53","author":"Y-H Song","year":"2021","unstructured":"Song Y-H, Yoon J, Lee S-H (2021) The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders. Exp Mol Med 53:328\u2013338. https:\/\/doi.org\/10.1038\/s12276-021-00580-4","journal-title":"Exp Mol Med"},{"key":"6221_CR32","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.3390\/ijms22168434","volume":"22","author":"M Gonzalez-Rodriguez","year":"2021","unstructured":"Gonzalez-Rodriguez M, Astillero-Lopez V, Villanueva-Anguita P, Paya-Rodriguez ME, Flores-Cuadrado A, Villar-Conde S et al (2021) Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer\u2019s Disease. Int J Mol Sci 22:8434. https:\/\/doi.org\/10.3390\/ijms22168434","journal-title":"Int J Mol Sci"},{"key":"6221_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2022","unstructured":"Ashleigh T, Swerdlow RH, Beal MF (2022) The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19:333\u2013342. https:\/\/doi.org\/10.1002\/alz.12683","journal-title":"Alzheimers Dement"},{"key":"6221_CR34","doi-asserted-by":"publisher","first-page":"1588645","DOI":"10.3389\/fncel.2025.1588645","volume":"19","author":"T Liu","year":"2025","unstructured":"Liu T, Sun W, Guo S, Yuan Z, Zhu M, Lu J et al (2025) Role of mitochondrial quality control in neurodegenerative disease progression. Front Cell Neurosci 19:1588645. https:\/\/doi.org\/10.3389\/fncel.2025.1588645","journal-title":"Front Cell Neurosci"},{"key":"6221_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41422-025-01203-7","volume":"36","author":"Q Wang","year":"2026","unstructured":"Wang Q, Sun Y, Li TY, Auwerx J (2026) Mitophagy in the pathogenesis and management of disease. Cell Res 36:11\u201337. https:\/\/doi.org\/10.1038\/s41422-025-01203-7","journal-title":"Cell Res"},{"key":"6221_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X et al (2025) Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther 10:9. https:\/\/doi.org\/10.1038\/s41392-024-02044-3","journal-title":"Signal Transduct Target Ther"},{"key":"6221_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44324-025-00049-2","volume":"3","author":"F Borbolis","year":"2025","unstructured":"Borbolis F, Ploumi C, Palikaras K (2025) Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseases. NPJ Metab Health Dis 3:4. https:\/\/doi.org\/10.1038\/s44324-025-00049-2","journal-title":"NPJ Metab Health Dis"},{"key":"6221_CR38","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.neuron.2025.03.003","volume":"113","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhou L, Wang N, Qiu B, Yao D, Yu J et al (2025) Comprehensive characterization of metabolic consumption and production by the human brain. Neuron 113:1708-1722.e5. https:\/\/doi.org\/10.1016\/j.neuron.2025.03.003","journal-title":"Neuron"},{"key":"6221_CR39","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.1038\/s41467-025-64201-8","volume":"16","author":"F Fang","year":"2025","unstructured":"Fang F, Wang E, Yang H, Zhao T, Wang Q, Zhang Z et al (2025) Reprogramming mitochondrial metabolism and epigenetics of macrophages via miR-10a liposomes for atherosclerosis therapy. Nat Commun 16:9117. https:\/\/doi.org\/10.1038\/s41467-025-64201-8","journal-title":"Nat Commun"},{"key":"6221_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/labinvest.2011.145","volume":"92","author":"L Ebermann","year":"2012","unstructured":"Ebermann L, Wika S, Klumpe I, Hammer E, Klingel K, Lassner D et al (2012) The mitochondrial respiratory chain has a critical role in the antiviral process in Coxsackievirus B3-induced myocarditis. Lab Invest 92:125\u2013134. https:\/\/doi.org\/10.1038\/labinvest.2011.145","journal-title":"Lab Invest"},{"key":"6221_CR41","doi-asserted-by":"publisher","first-page":"1772036","DOI":"10.3389\/fneur.2026.1772036","volume":"17","author":"X Xiao","year":"2026","unstructured":"Xiao X, Yan X, Liang C, Yang Y (2026) Metabolic dysfunction and mitochondrial failure in Alzheimer\u2019s disease: integrating pathophysiology, clinical evidence and emerging interventions. Front Neurol 17:1772036. https:\/\/doi.org\/10.3389\/fneur.2026.1772036","journal-title":"Front Neurol"},{"key":"6221_CR42","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","volume":"33","author":"R Wasim","year":"2025","unstructured":"Wasim R (2025) Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer\u2019s disease. Inflammopharmacology 33:5273\u20135289. https:\/\/doi.org\/10.1007\/s10787-025-01916-","journal-title":"Inflammopharmacology"},{"key":"6221_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15051884","author":"RC Christodoulou","year":"2026","unstructured":"Christodoulou RC, Eller D, Papageorgiou PS, Angelopoulou E, Vassiliou E, Papageorgiou SG (2026) Metabolic dysfunction in Alzheimer\u2019s disease: brain glucose hypometabolism as an early precursor to amyloid and tau pathology. J Clin Med. https:\/\/doi.org\/10.3390\/jcm15051884","journal-title":"J Clin Med"},{"key":"6221_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-026-02583-x","author":"S Akter","year":"2026","unstructured":"Akter S, Madhuvilakku R, Kar AK, Nila IS, Liu P, Inuzuka H et al (2026) Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-026-02583-x","journal-title":"Signal Transduct Target Ther"},{"key":"6221_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.irn.2020.01.008","volume":"154","author":"RH Swerdlow","year":"2020","unstructured":"Swerdlow RH (2020) The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer\u2019s disease. Int Rev Neurobiol 154:207\u2013233. https:\/\/doi.org\/10.1016\/bs.irn.2020.01.008","journal-title":"Int Rev Neurobiol"},{"key":"6221_CR46","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.2174\/138161211798072517","volume":"17","author":"J Yao","year":"2011","unstructured":"Yao J, Brinton RD (2011) Targeting mitochondrial bioenergetics for Alzheimer\u2019s prevention and treatment. Curr Pharm Des 17:3474\u20133479. https:\/\/doi.org\/10.2174\/138161211798072517","journal-title":"Curr Pharm Des"},{"key":"6221_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101191","volume":"64","author":"JA Pradeepkiran","year":"2020","unstructured":"Pradeepkiran JA, Reddy PH (2020) Defective mitophagy in Alzheimer\u2019s disease. Ageing Res Rev 64:101191. https:\/\/doi.org\/10.1016\/j.arr.2020.101191","journal-title":"Ageing Res Rev"},{"key":"6221_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70319","volume":"6","author":"L Ye","year":"2020","unstructured":"Ye L, Fu X, Li Q (2020) Mitochondrial quality control in health and disease. MedComm (2020) 6:e70319. https:\/\/doi.org\/10.1002\/mco2.70319","journal-title":"MedComm (2020)"},{"key":"6221_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105433","volume":"165","author":"XL Wang","year":"2021","unstructured":"Wang XL, Feng ST, Wang ZZ, Chen NH, Zhang Y (2021) Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases. Pharmacol Res 165:105433. https:\/\/doi.org\/10.1016\/j.phrs.2021.105433","journal-title":"Pharmacol Res"},{"key":"6221_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/10738584221139761","volume":"30","author":"JA Pradeepkiran","year":"2023","unstructured":"Pradeepkiran JA, Baig J, Seman A, Reddy PH (2023) Mitochondria in aging and Alzheimer\u2019s disease: focus on mitophagy. Neuroscientist 30:440\u2013457. https:\/\/doi.org\/10.1177\/10738584221139761","journal-title":"Neuroscientist"},{"key":"6221_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z et al (2023) PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 84:101817. https:\/\/doi.org\/10.1016\/j.arr.2022.101817","journal-title":"Ageing Res Rev"},{"key":"6221_CR52","doi-asserted-by":"publisher","first-page":"1460286","DOI":"10.3389\/fimmu.2024.1460286","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhang J, Deng Q, Chen X (2024) Mitophagy-associated programmed neuronal death and neuroinflammation. Front Immunol 15:1460286. https:\/\/doi.org\/10.3389\/fimmu.2024.1460286","journal-title":"Front Immunol"},{"key":"6221_CR53","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1080\/15548627.2020.1810919","volume":"16","author":"S Han","year":"2020","unstructured":"Han S, Jeong YY, Sheshadri P, Cai Q (2020) Mitophagy coordination with retrograde transport ensures the integrity of synaptic mitochondria. Autophagy 16:1925\u20131927. https:\/\/doi.org\/10.1080\/15548627.2020.1810919","journal-title":"Autophagy"},{"key":"6221_CR54","doi-asserted-by":"publisher","first-page":"1542369","DOI":"10.3389\/fimmu.2025.1542369","volume":"16","author":"Y Ma","year":"2025","unstructured":"Ma Y, Song R, Duan C (2025) Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation. Front Immunol 16:1542369. https:\/\/doi.org\/10.3389\/fimmu.2025.1542369","journal-title":"Front Immunol"},{"key":"6221_CR55","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.4103\/nrr.Nrr-d-24-01571","volume":"21","author":"KA Cicali","year":"2026","unstructured":"Cicali KA, Torres AK, Tapia-Rojas C (2026) Synaptic mitochondria in aging and neurodegenerative diseases: Functional decline and vulnerability. Neural Regen Res 21:2145\u20132152. https:\/\/doi.org\/10.4103\/nrr.Nrr-d-24-01571","journal-title":"Neural Regen Res"},{"key":"6221_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40035-022-00305-1","volume":"11","author":"K Zeng","year":"2022","unstructured":"Zeng K, Yu X, Mahaman YAR, Wang JZ, Liu R, Li Y et al (2022) Defective mitophagy and the etiopathogenesis of Alzheimer\u2019s disease. Transl Neurodegener 11:32. https:\/\/doi.org\/10.1186\/s40035-022-00305-1","journal-title":"Transl Neurodegener"},{"key":"6221_CR57","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/s41467-022-30431-3","volume":"13","author":"P Shi","year":"2022","unstructured":"Shi P, Ren X, Meng J, Kang C, Wu Y, Rong Y et al (2022) Mechanical instability generated by Myosin 19 contributes to mitochondria cristae architecture and OXPHOS. Nat Commun 13:2673. https:\/\/doi.org\/10.1038\/s41467-022-30431-3","journal-title":"Nat Commun"},{"key":"6221_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2025.100285","volume":"4","author":"J Yu","year":"2025","unstructured":"Yu J, Luo Y, Lin J, Li Z, Fang Z, He H et al (2025) Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. Cell Insight 4:100285. https:\/\/doi.org\/10.1016\/j.cellin.2025.100285","journal-title":"Cell Insight"},{"key":"6221_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123755","volume":"235","author":"C Huang","year":"2023","unstructured":"Huang C, Deng K, Wu M (2023) Mitochondrial cristae in health and disease. Int J Biol Macromol 235:123755. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123755","journal-title":"Int J Biol Macromol"},{"key":"6221_CR60","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbamcr.2016.05.020","volume":"1864","author":"H Rampelt","year":"2017","unstructured":"Rampelt H, Zerbes RM, van der Laan M, Pfanner N (2017) Role of the mitochondrial contact site and cristae organizing system in membrane architecture and dynamics. Biochim Biophys Acta Mol Cell Res 1864:737\u2013746. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.05.020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"6221_CR61","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1016\/j.apsb.2025.04.019","volume":"15","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang K, Huang M, Shang D, He X, Wu Z et al (2025) Structures and functions of the MICOS: pathogenesis and therapeutic implications in Alzheimer\u2019s disease. Acta Pharm Sin B 15:2966\u20132984. https:\/\/doi.org\/10.1016\/j.apsb.2025.04.019","journal-title":"Acta Pharm Sin B"},{"key":"6221_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166798","volume":"1869","author":"JS Bhatti","year":"2023","unstructured":"Bhatti JS, Kaur S, Mishra J, Dibbanti H, Singh A, Reddy AP et al (2023) Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:166798. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166798","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"6221_CR63","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2174\/1871527321666220616094036","volume":"22","author":"L\u00c1 Monsalvo-Maraver","year":"2023","unstructured":"Monsalvo-Maraver L\u00c1, Maya-L\u00f3pez M, Rangel-L\u00f3pez E, T\u00fanez I, Tinkov AA, Skalny A et al (2023) Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer\u2019s Disease. CNS & Neurological Disorders - Drug Targets 22:1039\u20131056. https:\/\/doi.org\/10.2174\/1871527321666220616094036","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"key":"6221_CR64","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/jneurosci.2385-16.2017","volume":"37","author":"SH Baek","year":"2017","unstructured":"Baek SH, Park SJ, Jeong JI, Kim SH, Han J, Kyung JW et al (2017) Inhibition of Drp1 Ameliorates Synaptic Depression, A\u03b2 Deposition, and Cognitive Impairment in an Alzheimer\u2019s Disease Model. J Neurosci 37:5099\u20135110. https:\/\/doi.org\/10.1523\/jneurosci.2385-16.2017","journal-title":"J Neurosci"},{"key":"6221_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081111","author":"J Panes","year":"2023","unstructured":"Panes J, Nguyen TKO, Gao H, Christensen TA, Stojakovic A, Trushin S et al (2023) Partial inhibition of complex I restores mitochondrial morphology and mitochondria-ER communication in hippocampus of APP\/PS1 mice. Cells. https:\/\/doi.org\/10.3390\/cells12081111","journal-title":"Cells"},{"key":"6221_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42003-020-01584-y","volume":"4","author":"A Stojakovic","year":"2021","unstructured":"Stojakovic A, Trushin S, Sheu A, Khalili L, Chang SY, Li X et al (2021) Partial inhibition of mitochondrial complex I ameliorates Alzheimer\u2019s disease pathology and cognition in APP\/PS1 female mice. Commun Biol 4:61. https:\/\/doi.org\/10.1038\/s42003-020-01584-y","journal-title":"Commun Biol"},{"key":"6221_CR67","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tins.2022.01.005","volume":"45","author":"J Cisneros","year":"2022","unstructured":"Cisneros J, Belton TB, Shum GC, Molakal CG, Wong YC (2022) Mitochondria-lysosome contact site dynamics and misregulation in neurodegenerative diseases. Trends Neurosci 45:312\u2013322. https:\/\/doi.org\/10.1016\/j.tins.2022.01.005","journal-title":"Trends Neurosci"},{"key":"6221_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1418939","author":"Z Liao","year":"2024","unstructured":"Liao Z, Zhang Q, Ren N, Zhao H, Zheng X (2024) Progress in mitochondrial and omics studies in Alzheimer\u2019s disease research: from molecular mechanisms to therapeutic interventions. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1418939","journal-title":"Front Immunol"},{"key":"6221_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1293164","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang J, Chen H, Li X, Xu R, Gao F et al (2023) A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer\u2019s disease mouse models through attenuating mitochondrial function. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1293164","journal-title":"Front Aging Neurosci"},{"key":"6221_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104961","volume":"144","author":"MU Rehman","year":"2023","unstructured":"Rehman MU, Sehar N, Dar NJ, Khan A, Arafah A, Rashid S et al (2023) Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments. Neurosci Biobehav Rev 144:104961. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104961","journal-title":"Neurosci Biobehav Rev"},{"key":"6221_CR71","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antiox13020191","volume":"13","author":"Z Fi\u0161ar","year":"2024","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J (2024) CoQ10 and Mitochondrial Dysfunction in Alzheimer\u2019s Disease. Antioxidants 13:191. https:\/\/doi.org\/10.3390\/antiox13020191","journal-title":"Antioxidants"},{"key":"6221_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102734","volume":"63","author":"Y Han","year":"2023","unstructured":"Han Y, Liu D, Cheng Y, Ji Q, Liu M, Zhang B et al (2023) Maintenance of mitochondrial homeostasis for Alzheimer\u2019s disease: strategies and challenges. Redox Biol 63:102734. https:\/\/doi.org\/10.1016\/j.redox.2023.102734","journal-title":"Redox Biol"},{"key":"6221_CR73","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","volume":"193","author":"S Dewanjee","year":"2022","unstructured":"Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A et al (2022) Altered glucose metabolism in Alzheimer\u2019s disease: role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med 193:134\u2013157. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.032","journal-title":"Free Radic Biol Med"},{"key":"6221_CR74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Dadarao Chakole R et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis -an updated review. Mitochondrion 71:83\u201392. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007","journal-title":"Mitochondrion"},{"key":"6221_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u MC, Andronie-Cioara FL, Jurc\u0103u A, Marcu F, \u0162i\u021b DM, Pa\u0219cal\u0103u N et al (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants (Basel) 11:2167. https:\/\/doi.org\/10.3390\/antiox11112167","journal-title":"Antioxidants (Basel)"},{"key":"6221_CR76","doi-asserted-by":"publisher","unstructured":"Chakravorty A, Jetto C T, Manjithaya R (2019) Dysfunctional mitochondria and mitophagy as drivers of Alzheimer\u2019s Disease Pathogenesis. Front Aging Neurosci 11.\u00a0https:\/\/doi.org\/10.3389\/fnagi.2019.00311","DOI":"10.3389\/fnagi.2019.00311"},{"key":"6221_CR77","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","volume":"172","author":"H Morton","year":"2021","unstructured":"Morton H, Kshirsagar S, Orlov E, Bunquin LE, Sawant N, Boleng L et al (2021) Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: Focus on aging, mitochondria and synapse. Free Radical Biol Med 172:652\u2013667. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.07.013","journal-title":"Free Radical Biol Med"},{"key":"6221_CR78","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41593-020-0652-4","volume":"23","author":"S Poll","year":"2020","unstructured":"Poll S, Mittag M, Musacchio F, Justus LC, Giovannetti EA, Steffen J et al (2020) Memory trace interference impairs recall in a mouse model of Alzheimer\u2019s disease. Nat Neurosci 23:952\u2013958. https:\/\/doi.org\/10.1038\/s41593-020-0652-4","journal-title":"Nat Neurosci"},{"key":"6221_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107162","volume":"217","author":"J Wei","year":"2025","unstructured":"Wei J, Xiao T, Lyu J, Zhao Y, Zhang Y, Du X et al (2025) Mitophagy in Alzheimer\u2019s disease and its potential as a therapeutic target. Neurobiol Dis 217:107162. https:\/\/doi.org\/10.1016\/j.nbd.2025.107162","journal-title":"Neurobiol Dis"},{"key":"6221_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00305-1","author":"K Zeng","year":"2022","unstructured":"Zeng K, Yu X, Mahaman YAR, Wang J-Z, Liu R, Li Y et al (2022) Defective mitophagy and the etiopathogenesis of Alzheimer\u2019s disease. Transl Neurodegener. https:\/\/doi.org\/10.1186\/s40035-022-00305-1","journal-title":"Transl Neurodegener"},{"key":"6221_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mito.2021.04.007","volume":"59","author":"X-J Pan","year":"2021","unstructured":"Pan X-J, Misrani A, Tabassum S, Yang L (2021) Mitophagy pathways and Alzheimer\u2019s disease: From pathogenesis to treatment. Mitochondrion 59:37\u201347. https:\/\/doi.org\/10.1016\/j.mito.2021.04.007","journal-title":"Mitochondrion"},{"key":"6221_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00391","author":"C Xie","year":"2020","unstructured":"Xie C, Aman Y, Adriaanse BA, Cader MZ, Plun-Favreau H, Xiao J et al (2020) Culprit or bystander: defective mitophagy in Alzheimer\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2019.00391","journal-title":"Front Cell Dev Biol"},{"key":"6221_CR83","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1007\/s10787-025-01859-y","volume":"33","author":"P Goleij","year":"2025","unstructured":"Goleij P, Khazeei Tabari MA, Poudineh M, Sanaye PM, Khan H, Kumar AP et al (2025) Therapeutic potential of melatonin-induced mitophagy in the pathogenesis of Alzheimer\u2019s disease. Inflammopharmacology 33:4553\u20134575. https:\/\/doi.org\/10.1007\/s10787-025-01859-y","journal-title":"Inflammopharmacology"},{"key":"6221_CR84","doi-asserted-by":"publisher","unstructured":"Zhang Y, Yuan J, Wu RP, Hu XJ, Gao FL, Sun YQ (2024) The role of somatostatin in Alzheimer's Disease: modulation of NLRP3-mediated microglial pyroptosis via the MDM2\/DPP4\/Sirt1 axis.\u00a0J Biol Regul Homeost Agents\u00a038:https:\/\/doi.org\/10.23812\/j.biol.regul.homeost.agents.20243803.171","DOI":"10.23812\/j.biol.regul.homeost.agents.20243803.171"},{"key":"6221_CR85","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1124\/pharmrev.124.001117","volume":"76","author":"KE Sandoval","year":"2024","unstructured":"Sandoval KE, Witt KA (2024) Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting. Pharmacol Rev 76:1291\u20131325. https:\/\/doi.org\/10.1124\/pharmrev.124.001117","journal-title":"Pharmacol Rev"},{"key":"6221_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102955","volume":"68","author":"G Liu","year":"2023","unstructured":"Liu G, Yang C, Wang X, Chen X, Wang Y, Le W (2023) Oxygen metabolism abnormality and Alzheimer\u2019s disease: An update. Redox Biol 68:102955. https:\/\/doi.org\/10.1016\/j.redox.2023.102955","journal-title":"Redox Biol"},{"key":"6221_CR87","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41422-022-00679-x","volume":"32","author":"W Zhao","year":"2022","unstructured":"Zhao W, Han S, Qiu N, Feng W, Lu M, Zhang W et al (2022) Structural insights into ligand recognition and selectivity of somatostatin receptors. Cell Res 32:761\u2013772. https:\/\/doi.org\/10.1038\/s41422-022-00679-x","journal-title":"Cell Res"},{"key":"6221_CR88","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/13872877251392782","volume":"109","author":"P Nilsson","year":"2025","unstructured":"Nilsson P, S\u00f6rgjerd K, Kakiya N, Sasaguri H, Watamura N, Johansson L et al (2025) Somatostatin receptor subtypes 1 and 4 regulate neprilysin, the major amyloid-\u03b2 degrading enzyme in brain. Journal of Alzheimer\u2019s Disease 109:651\u2013666. https:\/\/doi.org\/10.1177\/13872877251392782","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"6221_CR89","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/s41401-024-01314-8","volume":"45","author":"Y-g Li","year":"2024","unstructured":"Li Y-g, Meng X-y, Yang X, Ling S-l, Shi P, Tian C-l et al (2024) Structural insights into somatostatin receptor 5 bound with cyclic peptides. Acta Pharmacol Sin 45:2432\u20132440. https:\/\/doi.org\/10.1038\/s41401-024-01314-8","journal-title":"Acta Pharmacol Sin"},{"key":"6221_CR90","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.csbj.2024.03.005","volume":"23","author":"C Guccione","year":"2024","unstructured":"Guccione C, Gervasoni S, \u00d6zt\u00fcrk I, Bosin A, Ruggerone P, Malloci G (2024) Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations. Comput Struct Biotechnol J 23:1311\u20131319. https:\/\/doi.org\/10.1016\/j.csbj.2024.03.005","journal-title":"Comput Struct Biotechnol J"},{"key":"6221_CR91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/cancers16010116","volume":"16","author":"A Milewska-Kranc","year":"2023","unstructured":"Milewska-Kranc A, \u0106wik\u0142a JB, Kolasinska-\u0106wik\u0142a A (2023) The Role of Receptor-Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors. Cancers 16:116. https:\/\/doi.org\/10.3390\/cancers16010116","journal-title":"Cancers"},{"key":"6221_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1124\/jpet.122.539230","volume":"385","author":"K Bajgain","year":"2023","unstructured":"Bajgain K, Sandoval K, Magee A, Farr SA, Niehoff M, Witt K (2023) Novel Somatostatin Receptor Subtype-4 Agonist Enhances Memory and Neprilysin Enzyme Activity in Senescence Accelerated Mouse-Prone 8 Model of Cognitive Decline. J Pharmacol Exp Ther 385:137. https:\/\/doi.org\/10.1124\/jpet.122.539230","journal-title":"J Pharmacol Exp Ther"},{"key":"6221_CR93","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1007\/s11064-019-02890-6","volume":"44","author":"K Sandoval","year":"2019","unstructured":"Sandoval K, Umbaugh D, House A, Crider A, Witt K (2019) Somatostatin receptor subtype-4 regulates mRNA expression of amyloid-beta degrading enzymes and microglia mediators of phagocytosis in brains of 3xTg-AD mice. Neurochem Res 44:2670\u20132680. https:\/\/doi.org\/10.1007\/s11064-019-02890-6","journal-title":"Neurochem Res"},{"key":"6221_CR94","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1210\/mend.11.7.9943","volume":"11","author":"JJ Tentler","year":"1997","unstructured":"Tentler JJ, Hadcock JR, Gutierrez-Hartmann A (1997) Somatostatin acts by inhibiting the cyclic 3\u2019,5\u2019-adenosine monophosphate (cAMP)\/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency. Mol Endocrinol 11:859\u2013866. https:\/\/doi.org\/10.1210\/mend.11.7.9943","journal-title":"Mol Endocrinol"},{"key":"6221_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2023.102757","volume":"113","author":"P Garcia-Casas","year":"2023","unstructured":"Garcia-Casas P, Rossini M, Filadi R, Pizzo P (2023) Mitochondrial Ca2+ signaling and Alzheimer\u2019s disease: too much or too little? Cell Calcium 113:102757. https:\/\/doi.org\/10.1016\/j.ceca.2023.102757","journal-title":"Cell Calcium"},{"key":"6221_CR96","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jare.2024.02.013","volume":"68","author":"J Wang","year":"2025","unstructured":"Wang J, Jiang J, Hu H, Chen L (2025) MCU complex: Exploring emerging targets and mechanisms of mitochondrial physiology and pathology. J Adv Res 68:271\u2013298. https:\/\/doi.org\/10.1016\/j.jare.2024.02.013","journal-title":"J Adv Res"},{"key":"6221_CR97","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1038\/s44318-024-00219-w","volume":"43","author":"H Delgado de la Herran","year":"2024","unstructured":"Delgado de la Herran H, Vecellio Reane D, Cheng Y, Katona M, Hosp F, Greotti E et al (2024) Systematic mapping of mitochondrial calcium uniporter channel (MCUC)-mediated calcium signaling networks. EMBO J 43:5288\u20135326. https:\/\/doi.org\/10.1038\/s44318-024-00219-w","journal-title":"EMBO J"},{"key":"6221_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41401-024-01359-9","volume":"46","author":"W-b Zhao","year":"2024","unstructured":"Zhao W-b, Sheng R (2024) The correlation between mitochondria-associated endoplasmic reticulum membranes (MAMs) and Ca2+ transport in the pathogenesis of diseases. Acta Pharmacol Sin 46:271\u2013291. https:\/\/doi.org\/10.1038\/s41401-024-01359-9","journal-title":"Acta Pharmacol Sin"},{"key":"6221_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109649","volume":"72","author":"CR Sussman","year":"2020","unstructured":"Sussman CR, Wang X, Chebib FT, Torres VE (2020) Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling. Cell Signal 72:109649. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109649","journal-title":"Cell Signal"},{"key":"6221_CR100","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/19336950.2015.1018000","volume":"9","author":"ME Hildebrand","year":"2015","unstructured":"Hildebrand ME, Snutch TP (2015) The unusual suspects: Regulation of retinal calcium channels by somatostatin. Channels (Austin) 9:61\u201362. https:\/\/doi.org\/10.1080\/19336950.2015.1018000","journal-title":"Channels (Austin)"},{"key":"6221_CR101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2402491121","author":"P Hasan","year":"2024","unstructured":"Hasan P, Berezhnaya E, Rodr\u00edguez-Prados M, Weaver D, Bekeova C, Cartes-Saavedra B et al (2024) MICU1 and MICU2 control mitochondrial calcium signaling in the mammalian heart. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2402491121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6221_CR102","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13062-025-00633-y","volume":"20","author":"R Monzani","year":"2025","unstructured":"Monzani R, Gagliardi M, Saverio V, Clemente N, Monzani A, Rabbone I et al (2025) The CXCR3\/PLC\/IP3-IP3R axis is responsible for the ignition of UPR in intestinal epithelial cells exposed to gliadin peptide, during the onset of celiac disease. Biol Direct 20:39. https:\/\/doi.org\/10.1186\/s13062-025-00633-y","journal-title":"Biol Direct"},{"key":"6221_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105123","volume":"146","author":"BC Orem","year":"2020","unstructured":"Orem BC, Rajaee A, Stirling DP (2020) IP3R-mediated intra-axonal Ca2+ release contributes to secondary axonal degeneration following contusive spinal cord injury. Neurobiol Dis 146:105123. https:\/\/doi.org\/10.1016\/j.nbd.2020.105123","journal-title":"Neurobiol Dis"},{"key":"6221_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mucimm.2024.02.001","volume":"17","author":"R Yu","year":"2024","unstructured":"Yu R, Liu S, Li Y, Lu L, Huang S, Chen X et al (2024) TRPV1+ sensory nerves suppress conjunctival inflammation via SST-SSTR5 signaling in murine allergic conjunctivitis. Mucosal Immunol 17:211\u2013225. https:\/\/doi.org\/10.1016\/j.mucimm.2024.02.001","journal-title":"Mucosal Immunol"},{"key":"6221_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2024.114478","volume":"351","author":"AF Boan","year":"2024","unstructured":"Boan AF, Delgadin TH, Canosa LF, Fernandino JI (2024) Loss of function in somatostatin receptor 5 has no impact on the growth of medaka fish due to compensation by the other paralogs. Gen Comp Endocrinol 351:114478. https:\/\/doi.org\/10.1016\/j.ygcen.2024.114478","journal-title":"Gen Comp Endocrinol"},{"key":"6221_CR106","doi-asserted-by":"publisher","first-page":"251525642412292","DOI":"10.1177\/25152564241229273","volume":"7","author":"G Csord\u00e1s","year":"2024","unstructured":"Csord\u00e1s G, Weaver D, V\u00e1rnai P, Hajn\u00f3czky G (2024) Supralinear Dependence of the IP(3) Receptor-to-Mitochondria Local Ca(2+) Transfer on the Endoplasmic Reticulum Ca(2+) Loading. Contact (Thousand Oaks) 7:25152564241229270. https:\/\/doi.org\/10.1177\/25152564241229273","journal-title":"Contact (Thousand Oaks)"},{"key":"6221_CR107","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-024-00702-2","volume":"19","author":"M Calvo-Rodriguez","year":"2024","unstructured":"Calvo-Rodriguez M, Kharitonova EK, Snyder AC, Hou SS, Sanchez-Mico MV, Das S et al (2024) Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid \u03b2 aggregates in vivo in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener 19:6. https:\/\/doi.org\/10.1186\/s13024-024-00702-2","journal-title":"Mol Neurodegener"},{"key":"6221_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010027","author":"S Paik","year":"2021","unstructured":"Paik S, Somvanshi RK, Oliveira HA, Zou S, Kumar U (2021) Somatostatin ameliorates \u03b2-amyloid-induced cytotoxicity via the regulation of CRMP2 phosphorylation and calcium homeostasis in SH-SY5Y cells. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9010027","journal-title":"Biomedicines"},{"key":"6221_CR109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/jad-190964","volume":"75","author":"DD Quintana","year":"2020","unstructured":"Quintana DD, Garcia JA, Anantula Y, Rellick SL, Engler-Chiurazzi EB, Sarkar SN et al (2020) Amyloid-\u03b2 Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells. J Alzheimers Dis 75:119\u2013138. https:\/\/doi.org\/10.3233\/jad-190964","journal-title":"J Alzheimers Dis"},{"key":"6221_CR110","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12964-025-02460-0","volume":"23","author":"S Shukla","year":"2025","unstructured":"Shukla S, Kadam AA, Goyani S, Jaiswal N, Samantaray K, Raghav D et al (2025) Cell-type-specific dysregulation of mitochondrial calcium signaling in Alzheimer\u2019s disease. Cell Commun Signal 23:472. https:\/\/doi.org\/10.1186\/s12964-025-02460-0","journal-title":"Cell Commun Signal"},{"key":"6221_CR111","doi-asserted-by":"publisher","first-page":"1322670","DOI":"10.3389\/fimmu.2024.1322670","volume":"15","author":"B Zhang","year":"2024","unstructured":"Zhang B, Feng H, Lin H, Li R (2024) Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS. Front Immunol 15:1322670. https:\/\/doi.org\/10.3389\/fimmu.2024.1322670","journal-title":"Front Immunol"},{"key":"6221_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.002","author":"MM Klemmensen","year":"2024","unstructured":"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B (2024) Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. https:\/\/doi.org\/10.1016\/j.neurot.2023.10.002","journal-title":"Neurotherapeutics"},{"key":"6221_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01527-3","author":"J Zhang","year":"2024","unstructured":"Zhang J, Jiang Y, Dong X, Meng Z, Ji L, Kang Y et al (2024) Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23\/PS45 mice through a mitophagy-mediated increase in ADAM10 \u03b1-secretase cleavage of APP. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-024-01527-3","journal-title":"Alzheimers Res Ther"},{"key":"6221_CR114","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mito.2020.08.003","volume":"55","author":"P Pantiya","year":"2020","unstructured":"Pantiya P, Thonusin C, Chattipakorn N, Chattipakorn SC (2020) Mitochondrial abnormalities in neurodegenerative models and possible interventions: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease. Mitochondrion 55:14\u201347. https:\/\/doi.org\/10.1016\/j.mito.2020.08.003","journal-title":"Mitochondrion"},{"key":"6221_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.960314","author":"OJ Olajide","year":"2022","unstructured":"Olajide OJ, La Rue C, Bergdahl A, Chapman CA (2022) Inhibiting amyloid beta (1\u201342) peptide-induced mitochondrial dysfunction prevents the degradation of synaptic proteins in the entorhinal cortex. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.960314","journal-title":"Front Aging Neurosci"},{"key":"6221_CR116","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mito.2021.04.006","volume":"59","author":"S Datta","year":"2021","unstructured":"Datta S, Jaiswal M (2021) Mitochondrial calcium at the synapse. Mitochondrion 59:135\u2013153. https:\/\/doi.org\/10.1016\/j.mito.2021.04.006","journal-title":"Mitochondrion"},{"key":"6221_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener 11:3. https:\/\/doi.org\/10.1186\/s40035-021-00278-7","journal-title":"Transl Neurodegener"},{"key":"6221_CR118","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/bs.irn.2020.01.006","volume":"154","author":"MP Mattson","year":"2020","unstructured":"Mattson MP (2020) Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer\u2019s disease: Amelioration by metabolic switching. Int Rev Neurobiol 154:191\u2013205. https:\/\/doi.org\/10.1016\/bs.irn.2020.01.006","journal-title":"Int Rev Neurobiol"},{"key":"6221_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13129","volume":"33","author":"AB Ali","year":"2023","unstructured":"Ali AB, Islam A, Constanti A (2023) The fate of interneurons, GABA(A) receptor sub-types and perineuronal nets in Alzheimer\u2019s disease. Brain Pathol 33:e13129. https:\/\/doi.org\/10.1111\/bpa.13129","journal-title":"Brain Pathol"},{"key":"6221_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29559-z","author":"D Williams","year":"2023","unstructured":"Williams D, Yan BQ, Wang H, Negm L, Sackmann C, Verkuyl C et al (2023) Somatostatin slows A\u03b2 plaque deposition in aged APPNL-F\/NL-F mice by blocking A\u03b2 aggregation. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-29559-z","journal-title":"Sci Rep"},{"key":"6221_CR121","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.50263","volume":"11","author":"F Rofo","year":"2021","unstructured":"Rofo F, Ugur Yilmaz C, Metzendorf N, Gustavsson T, Beretta C, Erlandsson A et al (2021) Enhanced neprilysin-mediated degradation of hippocampal A\u03b242 with a somatostatin peptide that enters the brain. Theranostics 11:789\u2013804. https:\/\/doi.org\/10.7150\/thno.50263","journal-title":"Theranostics"},{"key":"6221_CR122","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/acschemneuro.1c00303","volume":"12","author":"F Rofo","year":"2021","unstructured":"Rofo F, Sandbaumh\u00fcter FA, Chourlia A, Metzendorf NG, Morrison JI, Syv\u00e4nen S et al (2021) Wide-ranging effects on the brain proteome in a transgenic mouse model of Alzheimer\u2019s disease following treatment with a brain-targeting somatostatin peptide. ACS Chem Neurosci 12:2529\u20132541. https:\/\/doi.org\/10.1021\/acschemneuro.1c00303","journal-title":"ACS Chem Neurosci"},{"key":"6221_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2024.114889","volume":"463","author":"W Zheng","year":"2024","unstructured":"Zheng W, Li K, Zhong M, Wu K, Zhou L, Huang J et al (2024) Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5\u00d7FAD mice. Behav Brain Res 463:114889. https:\/\/doi.org\/10.1016\/j.bbr.2024.114889","journal-title":"Behav Brain Res"},{"key":"6221_CR124","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200216rrrr","author":"Y Dou","year":"2023","unstructured":"Dou Y, Tan Y (2023) Presequence protease reverses mitochondria\u2010specific amyloid\u2010\u03b2\u2010induced mitophagy to protect mitochondria. FASEB J. https:\/\/doi.org\/10.1096\/fj.202200216rrrr","journal-title":"FASEB J"},{"key":"6221_CR125","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jconrel.2024.01.059","volume":"367","author":"R Meng","year":"2024","unstructured":"Meng R, Yang X, Li Y, Zhang Q (2024) Extending dual-targeting upper-limit in liposomal delivery of lithospermic acid B for Alzheimer\u2019s mitochondrial revitalization. J Control Release 367:604\u2013619. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.059","journal-title":"J Control Release"},{"key":"6221_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11091655","volume":"11","author":"CM Pedrero-Prieto","year":"2021","unstructured":"Pedrero-Prieto CM, Fronti\u00f1\u00e1n-Rubio J, Alca\u00edn FJ, Dur\u00e1n-Prado M, Peinado JR, Rabanal-Ruiz Y (2021) Biological significance of the protein changes occurring in the cerebrospinal fluid of Alzheimer\u2019s disease patients: getting clues from proteomic studies. Diagnostics (Basel) 11:1655. https:\/\/doi.org\/10.3390\/diagnostics11091655","journal-title":"Diagnostics (Basel)"},{"key":"6221_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.903175","author":"ME Consens","year":"2022","unstructured":"Consens ME, Chen Y, Menon V, Wang Y, Schneider JA, De Jager PL et al (2022) Bulk and single-nucleus transcriptomics highlight intra-telencephalic and somatostatin neurons in Alzheimer\u2019s disease. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2022.903175","journal-title":"Front Mol Neurosci"},{"key":"6221_CR128","doi-asserted-by":"publisher","unstructured":"Tong T, Zhu C, Farrell J J, Khurshid Z, undefined u, Martin ER\u00a0et al (2024) Blood-derived mitochondrial DNA copy number is associated with Alzheimer disease, Alzheimer-related biomarkers and serum metabolites. Alzheim Res Ther 16:https:\/\/doi.org\/10.1186\/s13195-024-01601-w","DOI":"10.1186\/s13195-024-01601-w"},{"key":"6221_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01807-x","author":"F Eysert","year":"2024","unstructured":"Eysert F, Kinoshita P-F, Lagarde J, Lacas-Gervais S, Xicota L, Doroth\u00e9e G et al (2024) Mitochondrial alterations in fibroblasts from sporadic Alzheimer\u2019s disease (AD) patients correlate with AD-related clinical hallmarks. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-024-01807-x","journal-title":"Acta Neuropathol Commun"},{"key":"6221_CR130","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s12035-020-01945-y","volume":"57","author":"SN Rai","year":"2020","unstructured":"Rai SN, Singh C, Singh A, Singh MP, Singh BK (2020) Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer\u2019s Disease. Mol Neurobiol 57:3075\u20133088. https:\/\/doi.org\/10.1007\/s12035-020-01945-y","journal-title":"Mol Neurobiol"},{"key":"6221_CR131","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/life13040970","volume":"13","author":"RM Farsi","year":"2023","unstructured":"Farsi RM (2023) The Role of Mitochondrial Dysfunction in Alzheimer\u2019s: Molecular Defects and Mitophagy-Enhancing Approaches. Life 13:970. https:\/\/doi.org\/10.3390\/life13040970","journal-title":"Life"},{"key":"6221_CR132","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s12035-020-02248-y","volume":"58","author":"M Song","year":"2021","unstructured":"Song M, Zhao X, Song F (2021) Aging-Dependent Mitophagy Dysfunction in Alzheimer\u2019s Disease. Mol Neurobiol 58:2362\u20132378. https:\/\/doi.org\/10.1007\/s12035-020-02248-y","journal-title":"Mol Neurobiol"},{"key":"6221_CR133","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B et al (2019) Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22:401\u2013412. https:\/\/doi.org\/10.1038\/s41593-018-0332-9","journal-title":"Nat Neurosci"},{"key":"6221_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102732","volume":"108","author":"S Skawratananond","year":"2025","unstructured":"Skawratananond S, Xiong DX, Zhang C, Tonk S, Pinili A, Delacruz B et al (2025) Mitophagy in Alzheimer\u2019s disease and other metabolic disorders: A focus on mitochondrial-targeted therapeutics. Ageing Res Rev 108:102732. https:\/\/doi.org\/10.1016\/j.arr.2025.102732","journal-title":"Ageing Res Rev"},{"key":"6221_CR135","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells8050488","volume":"8","author":"PH Reddy","year":"2019","unstructured":"Reddy PH, Oliver DMA (2019) Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer\u2019s Disease. Cells 8:488. https:\/\/doi.org\/10.3390\/cells8050488","journal-title":"Cells"},{"key":"6221_CR136","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1039\/d4fo00520a","volume":"15","author":"Y Xie","year":"2024","unstructured":"Xie Y, Ke X, Ye Z, Li X, Chen Z, Liu J et al (2024) Se-methylselenocysteine ameliorates mitochondrial function by targeting both mitophagy and autophagy in the mouse model of Alzheimer\u2019s disease. Food Funct 15:4310\u20134322. https:\/\/doi.org\/10.1039\/d4fo00520a","journal-title":"Food Funct"},{"key":"6221_CR137","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1016\/j.apsb.2025.04.019","volume":"15","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang K, Huang M, Shang D, He X, Wu Z et al (2025) Structures and functions of the MICOS: Pathogenesis and therapeutic implications in Alzheimer\u2019s disease. Acta Pharmaceutica Sinica B 15:2966\u20132984. https:\/\/doi.org\/10.1016\/j.apsb.2025.04.01","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"6221_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116296","volume":"226","author":"J Ye","year":"2024","unstructured":"Ye J, Wu J, Ai L, Zhu M, Li Y, Yin D et al (2024) Geniposide effectively safeguards HT22 cells against A\u03b2-induced damage by activating mitophagy via the PINK1\/Parkin signaling pathway. Biochem Pharmacol 226:116296. https:\/\/doi.org\/10.1016\/j.bcp.2024.116296","journal-title":"Biochem Pharmacol"},{"key":"6221_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176057","volume":"959","author":"T-Y Zhou","year":"2023","unstructured":"Zhou T-Y, Ma R-X, Li J, Zou B, Yang H, Ma R-Y et al (2023) Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer\u2019s disease. Eur J Pharmacol 959:176057. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176057","journal-title":"Eur J Pharmacol"},{"key":"6221_CR140","doi-asserted-by":"publisher","first-page":"15919","DOI":"10.3390\/ijms242115919","volume":"24","author":"X Zheng","year":"2023","unstructured":"Zheng X, Liu K, Xie Q, Xin H, Chen W, Lin S et al (2023) PHB2 Alleviates Neurotoxicity of Prion Peptide PrP106\u2013126 via PINK1\/Parkin-Dependent Mitophagy. Int J Mol Sci 24:15919. https:\/\/doi.org\/10.3390\/ijms242115919","journal-title":"Int J Mol Sci"},{"key":"6221_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.133719","volume":"467","author":"M Liu","year":"2024","unstructured":"Liu M, Lu J, Hu J, Chen Y, Deng X, Wang J et al (2024) Sodium sulfite triggered hepatic apoptosis, necroptosis, and pyroptosis by inducing mitochondrial damage in mice and AML-12 cells. J Hazard Mater 467:133719. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.133719","journal-title":"J Hazard Mater"},{"key":"6221_CR142","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3724\/abbs.2022138","volume":"54","author":"H Cai","year":"2022","unstructured":"Cai H, Qiao J, Chen S, Yang J, H\u00f6lscher C, Wang Z et al (2022) <italic>MCU<\/italic> knockdown in hippocampal neurons improves memory performance of an Alzheimer&rsquo;s disease mouse model. Acta Biochim Biophys Sin 54:1528\u20131539. https:\/\/doi.org\/10.3724\/abbs.2022138","journal-title":"Acta Biochim Biophys Sin"},{"key":"6221_CR143","doi-asserted-by":"publisher","unstructured":"Cai H-Y, Qiao J, Chen S-R, Fan W-P (2022) Mitochondrial calcium uniporter knockdown in hippocampal neurons improved the learning and memory dysfunction of Alzheimer\u2019s disease mice. Acta Physiologica Sinica 74(5):715\u2013725. https:\/\/doi.org\/10.13294\/j.aps.2022.0081","DOI":"10.13294\/j.aps.2022.0081"},{"key":"6221_CR144","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.3390\/ijms24109067","volume":"24","author":"D Baracaldo-Santamar\u00eda","year":"2023","unstructured":"Baracaldo-Santamar\u00eda D, Avenda\u00f1o-Lopez SS, Ariza-Salamanca DF, Rodriguez-Giraldo M, Calderon-Ospina CA, Gonz\u00e1lez-Reyes RE et al (2023) Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer\u2019s Disease. Int J Mol Sci 24:9067. https:\/\/doi.org\/10.3390\/ijms24109067","journal-title":"Int J Mol Sci"},{"key":"6221_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203869","author":"C Liu","year":"2023","unstructured":"Liu C, Li HJ, Duan WX, Duan Y, Yu Q, Zhang T et al (2023) MCU upregulation overactivates mitophagy by promoting VDAC1 dimerization and ubiquitination in the hepatotoxicity of cadmium. Advanced science (Weinheim, Baden-Wurttemberg, Germany). https:\/\/doi.org\/10.1002\/advs.202203869","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"6221_CR146","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/cells13100790","volume":"13","author":"M Tanaka","year":"2024","unstructured":"Tanaka M, Battaglia S, Gim\u00e9nez-Llort L, Chen C, Hepsomali P, Avenanti A et al (2024) Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry. Cells 13:790. https:\/\/doi.org\/10.3390\/cells13100790","journal-title":"Cells"},{"key":"6221_CR147","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmet.2023.01.007","volume":"35","author":"SH Elsea","year":"2023","unstructured":"Elsea SH, Posey JE (2023) Metabolic individuality: limitations, challenges, and potential for clinical utility. Cell Metab 35:233\u2013235. https:\/\/doi.org\/10.1016\/j.cmet.2023.01.007","journal-title":"Cell Metab"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06221-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:02:25Z","timestamp":1790272945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06221-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6221"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06221-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"920"}}